SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Bradpalm1 who wrote (2537)11/16/1997 8:28:00 PM
From: Gene Voss  Respond to of 23519
 
BRAD: The combination therapy has always been the desired approach.I'm not aware of the specific drugs being considered but combinations that involve different mechanisms of action,smooth muscle relxation,alpha blockers,possibly beta agonists,even PDE inhibitors would be likely candidates.
I'm not aware of the status of the case but its significance to Vivus appears limited.


GV.



To: Bradpalm1 who wrote (2537)11/17/1997 6:38:00 AM
From: James Baker  Read Replies (2) | Respond to of 23519
 
Brad, I hope those nice positive surprises are still on the horizon. You have been pretty quiet lately. Do you have an update for us?
Jim